Abstract
Rare tumors in children are defined as any tumor occurring with an incidence of 2 or less per million children less than 18 years of age. In the current chapter, we will describe a selection of rare tumors including lung tumors such as pleuropulmonary blastoma, abdominal tumors including desmoplastic round blue cell tumor, pancreatoblastoma, solid pseudopapillary tumor of the pancreas, gastrointestinal stromal tumor, neuroendocrine tumors, and pediatric colorectal carcinomas, as well as adrenocortical carcinomas. We describe the presentation, diagnosis, and management of these tumors including some controversies that presented over the last decades. Melanomas and rare sarcomas will be described in other chapters of this book. Several collaborative groups (EXPERT, COG, different tumor registries) have emerged and are collecting data on these tumors from a biological and outcomes perspective. These initiatives have allowed significant advances in the understanding of the genetics and biology of these tumors and will allow further targeted therapies through personalized medicine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
DeSantis CE, Kramer JL, Jemal A. The burden of rare cancers in the United States. CA Cancer J Clin. 2017;67:261–72.
Ferrari A, Bisogno G, De Salvo GL, et al. The challenge of very rare tumours in childhood: the Italian TREP project. Eur J Cancer. 2007;43:654–9.
Ferrari A, Brecht IB, Gatta G, et al. Defining and listing very rare cancers of paediatric age: consensus of the joint action on rare cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors. Eur J Cancer. 2019;110:120–6.
Pappo AS, Krailo M, Chen Z, Rodriguez-Galindo C, Reaman GG. Infrequent tumor initiative of the Children’s Oncology Group: initial lessons learned and their impact on future plans. J Clin Oncol. 2010;28:5011–6.
Weldon CB, Shamberger RC. Pediatric pulmonary tumors: primary and metastatic. Semin Pediatr Surg. 2008;17:17–29.
Knight S, Knight T, Khan A, Murphy AJ. Current management of pleuropulmonary blastoma: a surgical perspective. Children. 2019;6:86.
Dehner LP, Messinger YH, Schultz KA, et al. Pleuropulmonary blastoma: evolution of an entity as an entry into a familial tumor predisposition syndrome. Pediatr Dev Pathol. 2015;18:504–11.
Messinger YH, Stewart DR, Priest JR, et al. Pleuropulmonary blastoma: a report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry. Cancer. 2015;121:276–85.
Hill DA, Ivanovich J, Priest JR, et al. DICER1 mutations in familial pleuropulmonary blastoma. Science. 2009;325:965.
Foulkes WD, Priest JR, Duchaine TF. DICER1: mutations, microRNAs and mechanisms. Nat Rev Cancer. 2014;14(10):662–72.
Schultz KA, Yang J, Doros L, Williams GM, Harris A, Stewart DR, Messinger Y, Field A, Dehner LP, Hill DA. DICER1-pleuropulmonary blastoma familial tumor predisposition syndrome: a unique constellation of neoplastic conditions. Pathol Case Rev. 2014;19:90–100.
Hill DA, Jarzembowski JA, Priest JR, Williams G, Schoettler P, Dehner LP. Type I pleuropulmonary blastoma: pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry. Am J Surg Pathol. 2008;32:282–95.
Chowdhury MM, Chakraborty S. Imaging of congenital lung malformations. Semin Pediatr Surg. 2015;24:168–75.
Bisogno G, Brennan B, Orbach D, et al. Treatment and prognostic factors in pleuropulmonary blastoma: an EXPeRT report. Eur J Cancer. 2014;50:178–84.
Indolfi P, Casale F, Carli M, et al. Pleuropulmonary blastoma management and prognosis of 11 cases. Cancer. 2000;89:1396–401.
Pınarlı FG, Oguz A, Karadeniz C, Memis L, Poyraz A. Type II pleuropulmonary blastoma responsive to multimodal therapy. Pediatr Hematol Oncol. 2005;22:71–6.
Parsons SK, Fishman SJ, Hoorntje LE, et al. Aggressive multimodal treatment of pleuropulmonary blastoma. Ann Thorac Surg. 2001;72:939–42.
Boman F, Hill DA, William GM. Familial association of pleuropulmonary blastoma with cystic nephroma and other renal tumors: a report from the International Pleuropulmonary Blastoma Registry. J Pediatr. 2006;149:850.
Gerald WL, Ladanyi M, de Alava E, et al. Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J Clin Oncol. 1998;16:3028–36.
Ladanyi M, Gerald W. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res. 1994;54:2837–40.
Lettieri CK, Garcia-Filion P, Hingorani P. Incidence and outcomes of desmoplastic small round cell tumor: results from the surveillance, epidemiology, and end results database. J Cancer Epidemiol. 2014;2014:680126.
Hayes-Jordan A, Anderson P. Desmoplastic small round cell tumor: review of therapy including surgery followed by continuous hyperthermic peritoneal perfusion of chemotherapy. Oncol Rev. 2009;3:195–200.
Zhang WD, Li CX, Liu QY, et al. CT, MRI, and FDG-PET/CT imaging findings of abdominopelvic desmoplastic small round cell tumors: correlation with histopathologic findings. Eur J Radiol. 2011;80:269–73.
Gorospe L, Gómez T, González LM, et al. Desmoplastic small round cell tumor of the pelvis: MRI findings with histopathologic correlation. Eur Radiol. 2007;17:287–8.
Lal DR, Su WT, Wolden SL, et al. Results of multimodal treatment for desmoplastic small round cell tumors. J Pediatr Surg. 2005;40:251–5.
Hayes-Jordan A, Green H, Fitzgerald N, et al. Novel treatment for desmoplastic small round cell tumor: hyperthermic intraperitoneal perfusion. J Pediatr Surg. 2010;45:1000–6.
Hayes-Jordan AA, Coakley BA, Green HL, et al. Desmoplastic small round cell tumor treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: results of a phase 2 trial. Ann Surg Oncol. 2018;25:872–7.
Kushner BH, LaQuaglia MP, Wollner N, et al. Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. J Clin Oncol. 1996;14:1526–31.
Goodman KA, Wolden SL, La Quaglia MP, et al. Whole abdominopelvic radiotherapy for desmoplastic small round-cell tumor. Int J Radiat Oncol Biol Phys. 2002;54:170–6.
Desai NB, Stein NF, LaQuaglia MP. Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experience. Int J Radiat Oncol Biol Phys. 2013;85:67–72.
Hayes-Jordan A, Anderson P, Curley S, et al. Continuous hyperthermic peritoneal perfusion for desmoplastic small round cell tumor. J Pediatr Surg. 2007;42:E29–32.
Shorter NA, Glick RD, Klimstra DS. Malignant pancreatic tumors in childhood and adolescence: the memorial Sloan Kettering experience. J Pediatr Surg. 2002;37:887–92.
Vossen S, Goretzki PE, Goebel U, Willnow U. Therapeutic management of rare malignant pancreatic tumors in children. World J Surg. 1998;22:879–82.
Perez EA, Gutierrez JC, Koniaris LG, et al. Malignant pancreatic tumors: incidence and outcome in 58 pediatric patients. J Pediatr Surg. 2009;44:197–203.
Frable WJ, Still WJS, Kay S. Carcinoma of the pancreas. Infantile type. A light an electron microscopic study. Cancer. 1971;27:667–73.
Horie A, Yano Y, Kotoo Y, Miwa A. Morphogenesis of pancreatoblastoma, infantile carcinoma of the pancreas. Report of two cases. Cancer. 1997;39:247–54.
Ruol M, Sall’Igna P, Alaggio R, Toffolutti T, Cattarossi L, Gamba PG. Congenital pancreatoblastoma. J Pediatr Surg. 2015;3:120–2.
Abraham SC, Wu TT, Klinstra DS. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: frequent alteration in the APC/beta-catenin pathway and chromosome 11p. Am J Pathol. 2001;159:269–73.
Dhebri AR, Connor S, Campbell F. Diagnosis, treatment and outcome of pancreatoblastoma. Pancreatology. 2004;4:441–51.
Kaushal V, Goel A, Rattan KN, Yadav R, Mathur SK. Pancreatoblastoma. Indian J Pediatr. 2001;68:1075–7.
Levey JM, Banner BF. Adult pancreatoblastoma: a case report and review of the literature. Am J Gastroenterol. 1996;91:1841–4.
Kohda E, Iseki M, Ikawa H, Endoh M, Yokoyama J, Mukai M, Yamazaki H, Miyauchi J, Sacki M. Pancreatoblastoma: three original cases and review of literature. Acta Radiol. 2000;41:334–7.
Roebuck DJ, Yuen MK, Wong YC, Shing MK, Lee CW, Li CK. Imaging features of pancreatoblastoma. Pediatr Radiol. 2001;31:501–6.
Capelle J. Pancreatoblastoma. Ultrasound and CT imaging in one case. J Radiol. 1986;67:345–7.
Bien W, Godzinski J, Dall’Igna P. Pancreatoblastoma: a report from the European cooperative study group for paediatric rare tumours (EXPeRT). Eur J Cancer. 2011;47:2347–52.
Frantz VK. Atlas of tumor pathology. Washington, DC: Armed Forces Institute of Pathology; 1959.
Papavramidis T, Papavramidis S. Solid pseudopapillary tumors of the pancreas: review of 718 patients reported in English literature. J Am Coll Surg. 2005;200:965–72.
Lee SE, Jang JY, Hwang DW, Park KW, Kim SW. Clinical features and outcome of solid pseudopapillary neoplasm: differences between adults and children. Arch Surg. 2008;143:1218–21.
Lack EE, Levey R, Cassady JR, Vawter GF. Tumors of the exocrine pancreas in children and adolescents: a clinical and pathologic study of eight cases. Am J Surg Pathol. 1983;7:319–27.
Grosfeld JL, Vane DW, Rescorla FJ, McGuire W, West KW. Pancreatic tumors in childhood: analysis of 13 cases. J Pediatr Surg. 1990;25(10):1057–62.
Tanaka Y, Kato K, Notohara K, et al. Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm. Cancer Res. 2001;61:8401–4.
Machado MC, Machado MA, Bacchella T, Jukemura J, Almeida JL, Cunha JE. Solid pseudopapillary neoplasm of the pancreas: distinct patterns of onset, diagnosis and prognosis for male versus female patients. Surgery. 2008;143:29–34.
Mortenson MM, Katz MH, Tamm EP, Butani MS, Wang H, Evans DB, Fleming JB. Current diagnosis and management of unusual pancreatic tumors. Am J Surg. 2008;196:100–13.
Madan AK, Weldon CB, Long WP, Johnson D, Raafat A. Solid and papillary epithelial neoplasm of the pancreas. J Surg Oncol. 2004;85:193–8.
Zhang H, Liang TB, Wang WL, Shen Y, Ren GP, Zheng SS. Diagnosis and treatment of solid-pseudopapillary tumor of the pancreas. Hepatobiliary Pancreat Dis Int. 2006;5:454–8.
Jani N, Dewitt J, Eloubeidi M, et al. Endoscopic ultrasound-guided fine-needle aspiration for diagnosis of solid pseudopapillary tumors of the pancreas: a multicenter experience. Endoscopy. 2008;40:200–3.
Casadei R, Santini D, Calculli L, Pezzilli R, Zanini N, Minni F. Pancreatic solid cystic papillary tumor: clinical features, imaging findings and operative management. JOP. 2006;7:137–44.
Mao C, Guvendi M, Domenico DR, Kim K, Thomford NR, Howard JM. Papillary cystic and solid tumors of the pancreas: a pancreatic embryonic tumor? Studies of three cases and cumulative review of the world’s literature. Surgery. 1995;118:821–8.
Rebhandl W, Feiberbauer FX, Puig S, et al. Solid-pseudopapillary tumor of the pancreas (Frantz tumor) in children: report of four cases and review of literature. J Surg Oncol. 2001;76:289–96.
Strauss JF, Hirsch VJ, Rubey CN, Pollock M. Resection of a solid and papillary epithelial neoplasm of the pancreas following treatment with cis-platinum and 5-fluorouracil: a case report. Med Pediatr Oncol. 1993;21:365–7.
Fried P, Cooper J, Balthazar E, Fazzani E, Newall J. A role for radiotherapy in the treatment of solid and papillary neoplasms of the pancreas. Cancer. 1985;56:2783–5.
Law JK, Ahmed A, Singh VK, et al. A systematic review of solid pseudopapillary neoplasms: are these rare lesions? Pancreas. 2014;43:331–7.
Goh BK, Tan YM, Cheow PC, Chung AY, Chow PK, Wong WK, LL OO. Solid pseudopapillary neoplasms of the pancreas: an updated experience. J Surg Oncol. 2007;95:640–4.
Zhang H, Wang W, Shuangui Y, Xiao Y, Chen J. The prognosis and clinical characteristics of advanced (malignant) solid pseudopapillary neoplasm of the pancreas. Tumor Biol. 2016;37:5347–53.
Ladd AP, Grosfeld JL. Gastrointestinal tumors in children and adolescents. Semin Pediatr Surg. 2006;15:37–47.
Pappo AS, Janeway K, LaQuaglia M, Young SK. Special considerations in pediatric gastrointestinal tumors. J Surg Oncol. 2011;104:928–32.
Kaemmer DA, Otto J, Lassay L, et al. The GIST of literature on pediatric GIST: review of clinical presentation. J Pediatr Hematol Oncol. 2009;31:108–12.
Benesch M, Wardelmann E, Ferrari A, et al. Gastrointestinal stromal tumors (GIST) in children and adolescents: a comprehensive review of the current literature. Pediatr Blood Cancer. 2009;53:1171–9.
McWhinney SR, Pasini B, Stratakis CA, International Carney Triad and Carney–Stratakis Syndrome Consortium. Familial gastrointestinal stromal tumors and germ-line mutations. N Engl J Med. 2007;357:1054–6.
Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol. 2004;22:3813–25.
Scarpa M, Bertin M, Ruffolo C, et al. A systematic review on the clinical diagnosis of gastrointestinal stromal tumors. J Surg Oncol. 2008;98:384–92.
Hohenberger P, Ronellenfitsch U, Oladeji O, et al. Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour. Br J Surg. 2010;97:1854–9.
Hwang JH, Rulyak SD, Kimmey MB, American Gastroenterological Association Institute. American Gastroenterological Association Institute technical review on the management of gastric subepithelial masses. Gastroenterology. 2006;130:2217–28.
Pappo AS, Janeway KA. Pediatric gastrointestinal stromal tumors. Hematol Oncol Clin N Am. 2009;23:15–34.
Boikos SA, Stratakis CA. The genetic landscape of gastrointestinal stromal tumor lacking KIT and PDGFRA mutations. Endocrine. 2014;47:401–8.
Demetri GD. Differential properties of current tyrosine kinase inhibitors in gastrointestinal stromal tumors. Semin Oncol. 2011;38(Suppl 1):S10–9.
Mei L, Smith SC, Faber AC, et al. Gastrointestinal stromal tumors: the GIST of precision medicine. Trends Cancer. 2018;4:74–91.
Demetri GD, Benjamin RS, Blanke CD, et al. NCCN task force report: management of patients with gastrointestinal stromal tumor (GIST)—update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw. 2007;5(Suppl 2):S1–29.
Raut CP, Ashley SW. How i do it: surgical management of gastrointestinal stromal tumors. J Gastrointest Surg. 2008;12:1592–9.
Dematteo RP, Ballman KV, Antonescu CR, et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet. 2009;373:1097–104.
Attard TM, Lawson CE. Comparison of the demographic characteristics of pediatric and adult colorectal cancer patients: a national inpatient sample-based analysis. World J Pediatr. 2019;15:37–41.
Blumer SL, Anupindi SA, Adamson PC, Lin H, Price AP, Markowitz RI, et al. Sporadic adenocarcinoma of the colon in children. J Pediatr Hematol Oncol. 2012;34:137–41.
Sultan I, Rodriguez-Galindo C, El-Taani H, et al. Distinct features of colorectal cancer in children and adolescents: a population-based study of 159 cases. Cancer. 2010;116:758–65.
Fahy AS, Moir CR. Current approaches to pediatric polyposis syndromes. Clin Colon Rectal Surg. 2018;31:132–42.
Kayton ML. Cancer and pediatric inflammatory bowel disease. Semin Pediatr Surg. 2007;16:205–13.
Orlanski-Meyer E, Aardoom M, Ricciuto A, et al. Predicting outcomes in pediatric ulcerative colitis for management optimization: systematic review and consensus statements from the Pediatric Inflammatory Bowel Disease—ahead program. Gastroenterology. 2021;160:378–402.
Kim G, Baik S, Lee K, et al. Colon carcinoma in childhood: review of the literature with four case reports. Int J Colorectal Dis. 2013;28:157–64.
Weber ML, Schneider DT, Ofenmüller S, Kaatsch P, Einsiedel HG, Benesch M, et al. Pediatric colorectal carcinoma is associated with excellent outcome in the context of cancer predisposition syndromes. Pediatr Blood Cancer. 2016;63:611–7.
Chan GHJ, Chee CE. Making sense of adjuvant chemotherapy in colorectal cancer. J Gastrointest Oncol. 2019;10:1183–92.
Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2019;9(9):CD002200.
Degnan AJ, Tocchio S, Kurtom W, Tadros SS. Pediatric neuroendocrine carcinoid tumors: management, pathology, and imaging findings in a pediatric referral center. Pediatr Blood Cancer. 2017;64.
Malkan AD, Wahid FN, Fernandez-Pineda I, et al. Appendiceal carcinoid tumor in children: implications for less radical surgery? Clin Transl Oncol. 2015;17:127.
Fallon SC, Hicks MJ, Carpenter JL, Vasudevan SA, Nuchtern JG, Cass DL. Management of appendiceal carcinoid tumors in children. J Surg Res. 2015;198:384–7.
Kim SS, Kays DW, Larson SD, et al. Appendiceal carcinoids in children management and outcomes. J Surg Res. 2014;192:250.
Boudreaux JP, Klimstra DS, Hassan MM, et al. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum. Pancreas. 2010;39:753–66.
Ranaweera C, Brar A, Somers GR, Sheikh F, Pierro A, Zani A. Management of pediatric appendiceal carcinoid: a single institution experience from 5000 appendectomies. Pediatr Surg Int. 2019;35:1427–30.
Parikh PP, Perez EA, Neville HL, et al. Nationwide overview of survival and management of appendiceal tumors in children. J Pediatr Surg. 2018;53:1175–80.
Lobeck IN, Jeste N, Galler J, Pressey J, von Allmen D. Surgical management and surveillance of pediatric appendiceal carcinoid tumor. J Pediatr Surg. 2017;52:925–7.
Kulkarni KP, Sergi C. Appendix carcinoids in childhood: long-term experience at a single institution in western Canada and systematic review. Pediatr Int. 2013;55:157.
Lin X, Wu D, Chen C, Zheng N. Clinical characteristics of adrenal tumors in children: a retrospective review of a 15-year single-center experience. Int Urol Nephrol. 2017;49:381–5.
Mihai R. Rare adrenal tumors in children. Semin Pediatr Surg. 2014;23:71–5.
Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW. Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab. 2009;94:1853–78.
Lefebvre M, Foulkes WD. Pheochromocytoma and paraganglioma syndromes: genetics and management update. Curr Oncol. 2014;21:e8–e17.
Latronico AC, Chrousos GP. Adrenocortical tumours. J Clin Endocrinol Metab. 1997;82:1317–24.
Cecchetto G, Ganarin A, Bien E, et al. Outcome and prognostic factors in high-risk childhood adrenocortical carcinomas: a report from the European Cooperative Study Group on pediatric rare tumors (EXPeRT). Pediatr Blood Cancer. 2017;64:e26368.
Michalkiewicz E, Sandrini R, Figueiredo B, et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the international pediatric adrenocortical tumor registry. J Clin Oncol. 2004;22:838–45.
McDonnell CM, Zacharin MR. Adrenal cortical tumours: 25 years’ experience at the Royal Children’s Hospital, Melbourne. J Paediatr Child Health. 2003;39:682–5.
Patil KK, Ransley PG, McCullagh M, Malone M, Spitz L. Functioning adrenal neoplasms in children. BJU Int. 2002;89:562–5.
Driver CP, Birch J, Bruce J. Adrenal cortical tumors in childhood. Pediatr Hematol Oncol. 1998;15:527–32.
Ciftci AO, Senocak ME, Tanyel FC, Buyukpamukcu N. Adrenocortical tumors in children. J Pediatr Surg. 2001;36:549–54.
Flynt KA, Dillman JR, Davenport MS, Smith EA, Else T, Strouse PJ, Caoili EM. Pediatric adrenocortical neoplasms: can imaging reliably discriminate adenomas from carcinomas? Pediatr Radiol. 2015;45:1160–8.
Sandrini R, Ribeiro RC, DeLacerda L. Childhood adrenocortical tumors. J Clin Endocrinol Metab. 1997;82:2027–31.
Jones GS, Shah KJ, Mann JR. Adreno-cortical carcinoma in infancy and childhood: a radiological report of ten cases. Clin Radiol. 1985;36:257.
Daneman A, Chan HSL, Martin J. Adrenal carcinoma and adenoma in children. A review of 17 patients. Pediatr Radiol. 1985;13:11.
Ribeiro J, Ribeiro RC, Fletcher BD. Imaging findings in pediatric adrenocortical carcinoma. Pediatr Radiol. 2000;30:45–51.
Raymond VM, Else T, Everett JN, Long JM, Gruber SB, Hamme GD. Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma. J Clin Endocrinol Metab. 2013;98:E119–25.
Rescorla FJ. Malignant adrenal tumors. Semin Pediatr Surg. 2006;15:48–56.
Sedaghati M, Lin DT, Cisco RM, Kebebew E. Pediatric vs adult adrenocortical carcinoma: different rate of surgical treatment and patient outcome. Endocr Surg. 2019;229(S1):S81–2.
Rodriguez-Galindo C, Krailo MD, Pinto EM, et al. Treatment of pediatric adrenocortical carcinoma with surgery, retroperitoneal lymph node dissection, and chemotherapy: the Children’s Oncology Group ARAR0332 Protocol. J Clin Oncol. 2021;39(22):2463–73.
McAteer JP, Huaco JA, Gow KW. Predictors of survival in pediatric adrenocortical carcinoma: a Surveillance, Epidemiology, and End Results (SEER) program study. J Pediatr Surg. 2013;48:1025–31.
McFarlane DA. Cancer of adrenal cortex. Ann R Coll Surg Engl. 1958;23:155–86.
Pinto EM, Chen X, Easton J, et al. Genomic landscape of paediatric adrenocortical tumours. Nat Commun. 2015;6:6302.
Further Reading
Bien W, Godzinski J, Dall’igna P. Pancreatoblastoma: a report from the European cooperative study group for paediatric rare tumours (EXPeRT). Eur J Cancer. 2011;47:2347–52.
Degnan AJ, Tocchio S, Kurtom W, Tadros SS. Pediatric neuroendocrine carcinoid tumors: management, pathology, and imaging findings in a pediatric referral center. Pediatr Blood Cancer. 2017;64.
Ferrari A, Brecht IB, Gatta G, et al. Defining and listing very rare cancers of paediatric age: consensus of the joint action on rare cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors. Eur J Cancer. 2019;110:120–6.
Hayes-Jordan AA, Coakley BA, Green HL, et al. Desmoplastic small round cell tumor treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: results of a phase 2 trial. Ann Surg Oncol. 2018;25:872–7.
Ladd AP, Grosfeld JL. Gastrointestinal tumors in children and adolescents. Semin Pediatr Surg. 2006;15:37–47.
Madan AK, Weldon CB, Long WP, Johnson D, Raafat A. Solid and papillary epithelial neoplasm of the pancreas. J Surg Oncol. 2004;85:193–8.
Messinger YH, Stewart DR, Priest JR, et al. Pleuropulmonary blastoma: a report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry. Cancer. 2015;121:276–85.
Pappo AS, Krailo M, Chen Z, Rodriguez-Galindo C, Reaman GG. Infrequent tumor initiative of the Children’s Oncology Group: initial lessons learned and their impact on future plans. J Clin Oncol. 2010;28:5011–6.
Rodriguez-Galindo C, Krailo MD, Pinto EM, et al. Treatment of pediatric adrenocortical carcinoma with surgery, retroperitoneal lymph node dissection, and chemotherapy: the Children’s Oncology Group ARAR0332 protocol. J Clin Oncol. 2021;39(22):2463–73.
Sultan I, Rodriguez-Galindo C, El-Taani H, et al. Distinct features of colorectal cancer in children and adolescents: a population-based study of 159 cases. Cancer. 2010;116:758–65.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Fahy, A.S., Baertschiger, R.M. (2022). Uncommon Malignancies. In: Mattei, P. (eds) Fundamentals of Pediatric Surgery. Springer, Cham. https://doi.org/10.1007/978-3-031-07524-7_122
Download citation
DOI: https://doi.org/10.1007/978-3-031-07524-7_122
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-07523-0
Online ISBN: 978-3-031-07524-7
eBook Packages: MedicineMedicine (R0)